Status:
NOT_YET_RECRUITING
Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study)
Lead Sponsor:
Universität des Saarlandes
Collaborating Sponsors:
Universitatsmedizin Mainz - 1. Medizinische Klinik
Newcastle University
Conditions:
Steatotic Liver Disease
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
Eligibility:
All Genders
18+ years
Brief Summary
The rational to conduct the LOVE study builds on the lack of available data on outcomes in steatotic liver disease in well characterized patients over a time frame of several years. At current limited...
Eligibility Criteria
Inclusion
- Previous Informed consent for cohort studies
- \> 18 years of age
- Diagnosis of SLD (MASLD, MetALD, ALD)
Exclusion
- No consent for previous cohort studies
- \< 18 years of age
- No Diagnosis of SLD (MASLD, MetALD, ALD)
Key Trial Info
Start Date :
April 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2035
Estimated Enrollment :
30000 Patients enrolled
Trial Details
Trial ID
NCT06907563
Start Date
April 15 2025
End Date
December 31 2035
Last Update
April 2 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital de la Pitié Salpêtrière
Paris, France, 75013
2
University Medical Center Saarland, Department of Internal Medicine II
Homburg, Saarland, Germany, 66421
3
Division of Gastroenterology, Department of Medical Sciences, University of Turin
Turin, Italy
4
Translational & Clinical Research Institute Faculty of Medical Sciences
Newcastle upon Tyne, United Kingdom, NE2 4HH